Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) FCF Margin (2017 - 2025)

Nutex Health's FCF Margin history spans 16 years, with the latest figure at 46.41% for Q4 2025.

  • For Q4 2025, FCF Margin rose 4654.0% year-over-year to 46.41%; the TTM value through Dec 2025 reached 28.34%, up 2375.0%, while the annual FY2025 figure was 28.35%, 2400.0% up from the prior year.
  • FCF Margin for Q4 2025 was 46.41% at Nutex Health, up from 37.16% in the prior quarter.
  • Across five years, FCF Margin topped out at 1801.98% in Q1 2022 and bottomed at 46.46% in Q3 2022.
  • The 5-year median for FCF Margin is 11.03% (2021), against an average of 102.92%.
  • The largest annual shift saw FCF Margin surged 183014bps in 2022 before it crashed -180789bps in 2023.
  • A 5-year view of FCF Margin shows it stood at 10.89% in 2021, then soared by 112bps to 23.05% in 2022, then tumbled by -111bps to 2.55% in 2023, then surged by 95bps to 0.13% in 2024, then soared by 35123bps to 46.41% in 2025.
  • Per Business Quant, the three most recent readings for NUTX's FCF Margin are 46.41% (Q4 2025), 37.16% (Q3 2025), and 11.17% (Q2 2025).